Three days after the Republican Party gained control of the US Senate and rose to 250 seats in the House of Representatives, the airwaves are filled with bluster aimed at respective bases over what will become of the Affordable Care Act (ACA). While experts from both sides of the aisle agree that a full repeal is unlikely, 1 item has shown up on almost every early list of elements unlikely to survive the next Congress: the medical device tax.
Three days after the Republican Party gained control of the US Senate and rose to 250 seats in the House of Representatives, the airwaves are filled with bluster aimed at respective bases over what will become of the Affordable Care Act (ACA).
While experts from both sides of the aisle agree that a full repeal is unlikely, 1 item has shown up on almost every early list of elements unlikely to survive the next Congress: the medical device tax.
The 2.3 percent sales tax, more precisely called an excise tax by some experts, was included to help pay the costs of the 2010 law and applies to things like surgical gloves, dental instruments, stents, artificial knees and hips, defibrillators, pacemakers, irradiation equipment, and imaging technology. It does not apply to consumer items like eyeglasses and wheelchairs. In 2012, The Center on Budget and Policy Priorities estimated that total industry sales ranged between $106 and $116 billion.
The device industry has never let up in its opposition to the tax, and criticism mounted when early collections fell $300 million short of projections. Critics of the tax say it is threatening jobs, stifling innovation, and could shift jobs overseas in the long term. Economists and policy experts say these fears are overblown and insist that like the pharmaceutical industry, medical device makers profit enormously off minimal innovations rather than major breakthroughs.
Opposition to the tax crosses a unique spectrum in the Senate: everyone from incoming Senate Majority Leader Mitch McConnell to liberal stalwart US Senator Elizabeth Warren, D-Massachusetts, to Minnesota’s 2 Democrats, US Senators Al Franken and Amy Klobuchar, whose opposition reflects hometown advocacy for the state’s 28,500 medical technology workers, include those at industry leader Medtronic.
Because these key Democrats oppose this element but vow to retain other pieces that are more central to the ACA’s staying power, such as the individual mandate, the medical device tax is an obvious bargaining chip in the deal-making that is to come. Since Tuesday night, Republicans have promised to unravel what they can of Obamacare, vowing to go farther than experts predicted in the days leading up to Tuesday’s election. As House Speaker John Boehner, D-Ohio, said Wednesday, “Just because we may not be able to get everything we want doesn’t mean that we shouldn’t try to get what we can.”
Around the Web
With Republican Senate, many eye a device-tax repeal
Excise Tax on Medical Devices Should Not Be Repealed
Does Compromise With GOP Mean Adios for Device Tax?
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More